273 related articles for article (PubMed ID: 15305806)
1. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000.
Johnston GM; MacGarvie VL; Elliott D; Dewar RA; MacIntyre MM; Nolan MC
Clin Invest Med; 2004 Jun; 27(3):142-56. PubMed ID: 15305806
[TBL] [Abstract][Full Text] [Related]
2. Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
Rayson D; Saint-Jacques N; Younis T; Meadows J; Dewar R
CMAJ; 2007 Jan; 176(3):327-32. PubMed ID: 17261829
[TBL] [Abstract][Full Text] [Related]
3. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
4. Travel times to health care and survival from cancers in Northern England.
Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D
Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651
[TBL] [Abstract][Full Text] [Related]
5. Waiting times for access, diagnosis and treatment in a cancer centre.
Collins I; Naidoo J; Rowley S; Reynolds JV; Kennedy MJ
Ir Med J; 2009 Oct; 102(9):279-82. PubMed ID: 19902644
[TBL] [Abstract][Full Text] [Related]
6. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy waiting times for women with breast cancer: a population-based cohort study.
Jack RH; Davies EA; Robinson D; Sainsbury R; Møller H
BMC Cancer; 2007 May; 7():71. PubMed ID: 17472746
[TBL] [Abstract][Full Text] [Related]
8. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence after localized therapy for prostate cancer.
Moon K; Stukenborg GJ; Keim J; Theodorescu D
Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
[TBL] [Abstract][Full Text] [Related]
10. Identifying potential need for cancer palliation in Nova Scotia.
Johnston GM; Gibbons L; Burge FI; Dewar RA; Cummings I; Levy IG
CMAJ; 1998 Jun; 158(13):1691-8. PubMed ID: 9676544
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income.
Paszat LF; Mackillop WJ; Groome PA; Zhang-Salomons J; Schulze K; Holowaty E
Clin Invest Med; 1998 Jun; 21(3):125-34. PubMed ID: 9627766
[TBL] [Abstract][Full Text] [Related]
12. [Waiting times in breast disease clinics and psychological well-being: speedy care is better care].
Henselmans I; Sanderman R; Smink A; Ranchor AV; de Vries J
Ned Tijdschr Geneeskd; 2010; 154():B491. PubMed ID: 20170572
[TBL] [Abstract][Full Text] [Related]
13. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome.
E C; Dahrouge S; Samant R; Mirzaei A; Price J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1071-7. PubMed ID: 15752886
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
[TBL] [Abstract][Full Text] [Related]
15. Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?
Faria SL; Mahmud S; Wakil G; Negrete S; Souhami L; David M; Duclos M; Shenouda G; Freeman CR
Am J Clin Oncol; 2006 Oct; 29(5):463-7. PubMed ID: 17023780
[TBL] [Abstract][Full Text] [Related]
16. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
18. Waiting times for radiotherapy--a survey of patients' attitudes.
Lehman M; Jacob S; Delaney G; Papadatos G; Jalaludin B; Cail S; McCourt J; Wright S; O'Brien C; Barton M
Radiother Oncol; 2004 Mar; 70(3):283-9. PubMed ID: 15064014
[TBL] [Abstract][Full Text] [Related]
19. Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway.
Lewis NR; Le Jeune I; Baldwin DR
Br J Cancer; 2005 Oct; 93(8):905-8. PubMed ID: 16189521
[TBL] [Abstract][Full Text] [Related]
20. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
